Eleftherios (Terry) Papoutsakis, Ph.D.

University of Delaware

Since 2007, E. Terry Papoutsakis has been the Unidel Eugene DuPont Professor in the Departments of Chemical and Biomolecular Engineering and Biological Sciences at the Delaware Biotechnology Institute, University of Delaware. He received his undergraduate education at the National Technical University of Athens, Greece, and his M.S. and Ph.D. from Purdue University. He started his academic career at Rice University, moving later to Northwestern University, where he was appointed Walter P. Murphy Professor.

His group has made important contributions in Clostridium genetics and metabolic engineering, with applications in the biorenewables arena, and emphasis on complex, non-pathway dependent traits, such as tolerance to toxic chemicals. He is currently working on 2 major projects. One is to dissect and understand syntrophic Clostridium co-cultures that can effectively fix CO2 and improve renewable-carbon utilization. The second is to develop synthetic E.coli - based methylotrophic strains to convert natural gas to chemicals. He has trained over 65 Ph.D., 27 M.S. and 35 postdoctoral students through research funded by NIH, NSF, DOE, ARPA-E, ONR, ARO and EPA. He has published over 260 papers and has many issued or pending patents.
 
He was elected to the National Academy of Engineering and is a Fellow of the American Academy of Microbiology, American Chemical Society (ACS), AAAS and the American Institute of Chemical Engineers (AIChE). He received the 2017 ACS E. V. Murphree Award, the 2013 AIChE DIC Wang Award, the 2012 James E. Bailey Award, the 2010 Metabolic Engineering Award and the 2005 Amgen Biochemical Engineering.